HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors
about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesHodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRILEpstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infectionTissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infectionHepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cellsPremature B-cell senescence as a consequence of chronic immune activation.Modulation of human immune responses by bovine interleukin-10DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes.HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.Intestinal bacteria condition dendritic cells to promote IgA productionCD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infectionPolyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionFunctional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region.BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN)Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen.CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection.Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals.Immune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaInnate immune recognition and activation during HIV infection.Dendritic cell status modulates the outcome of HIV-related B cell disease progression.How do viruses trick B cells into becoming lymphomas?Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.Direct phenotypical and functional dysregulation of primary human B cells by human immunodeficiency virus (HIV) type 1 in vitro.Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodiesCritical issues in mucosal immunity for HIV-1 vaccine development.Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.B cells in HIV infection and diseaseViral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.B cell responses to HIV-1 infection and vaccination: pathways to preventing infection.HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscapeImmune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsAcquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment.An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cellsInitial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.
P2860
Q24624348-F70FF583-2190-4520-99CE-761D3DEFDF8BQ24681342-C6E92828-EE60-4487-933A-5985A98B7911Q27022706-E5C3F9CA-D372-4B5E-AE0B-D1D86BE3C248Q27347804-DC52E45C-8F99-4EA6-B9F0-40CA5A9988C4Q27487754-7807FE6F-BD38-4348-B4DE-A3FC01A1BAEFQ27693281-F84E6F12-2F96-4A27-8ABC-8376C179B9C8Q28741651-8B9CA500-3ADB-46E5-A880-BCC9201908ECQ33250086-D935BF53-35FA-49DC-A7AF-B5ED306CF35DQ33305012-4BFEB75C-2D01-4D57-B784-DE326C892E98Q33348616-BDB1862A-4E6D-4DF2-9800-0908FD408F89Q33438469-A9E6CF26-174B-4EAA-8D53-1DE5F4E3E712Q33479167-970F0F9E-98E8-48B5-8A99-81F19B2C87D5Q33508799-2EB59150-9548-4718-B8B7-27270F684508Q33573335-301825A1-8C42-4CB9-B7FF-ABE239FA2AE2Q33582027-28761771-5A67-4A9B-B90D-34E34DD08FA9Q33601372-011ED407-1A3A-48BB-8A5F-4843E211FCE7Q33613943-9A7AFD99-D4D0-4100-A75E-0BBDDF3A8DC4Q33631142-50ECBC79-71DE-4574-8060-D02F4E1CF795Q33719511-0A9B3A42-84FA-4AB8-AEA5-59A41910C259Q33745613-358AE758-717D-4524-ADB5-8004C412C633Q33808304-8EF534E2-DBDC-4683-8A2B-3E63E5804872Q33887336-E8DA4F51-1C0A-488B-9680-2A80EC7FB130Q33997880-21D80931-8BFA-4E8D-BD74-B795417C9E12Q34013594-DC350A4A-0CC4-4B63-815F-BA75E18409A0Q34020096-DB57C374-015D-4EDB-AF24-FE08C89F9B6CQ34324243-F9D352C4-5F1A-4818-9C80-79127E2A90FBQ34328961-BDED2296-D138-4B3A-ABC8-C3C30B6C526DQ34392963-A403001B-F2EB-4B51-B694-6219D3B9140DQ34459985-DADECBE9-9CB3-4735-9303-F26A87FC7C66Q34474354-85CD2BC8-8DA5-4682-8314-83D3DBB4D6D0Q34593647-B3A28639-A734-4FD2-A768-F43C66B11D39Q34605780-BAFC8E95-42E6-423D-8810-E20F36A55FABQ34624625-6C880FEA-F7A9-45F4-903A-417299C229DEQ34645502-CAE4665A-39DB-46C7-BB44-826E0C456E99Q34671009-AC63C4F6-BF2E-42F5-B7E8-A6127B97E75CQ34712244-B55BEDFD-934E-4121-8944-BFA35D7071F0Q34741868-8DE95947-8C28-4368-BB31-58482073256CQ34796885-39FD1443-8E61-4CA5-A584-F667D3C5AB2EQ34848486-5E2048EE-5764-4695-8A10-23BE9B6ED3A9Q34952914-D193E64C-4064-4095-BC1F-2CCF03DE3BE1
P2860
HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@ast
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@en
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@nl
type
label
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@ast
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@en
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@nl
prefLabel
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@ast
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@en
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@nl
P2093
P3181
P1476
HIV-1 envelope triggers polycl ...... FF and C-type lectin receptors
@en
P2093
Amy Chadburn
Andrea Cerutti
April Chiu
Daniel M Knowles
John P Moore
Per J Klasse
Xugang Qiao
P304
P3181
P356
10.4049/JIMMUNOL.176.7.3931
P407
P577
2006-04-01T00:00:00Z